The Mexico Bariatric Surgery Market is expected to grow during the forecast period. The major contributors in the market growth are the increasing burden of chronic diseases such as diabetes and heart diseases. Furthermore, the increase in the number of obese patients also helps in increasing the overall market.
According to the data of the International Diabetes Federation, 2020, the number of cases of diabetes in Mexico was recorded to be around 12,805,200. It constitutes about 15.2% of the total Mexican population. This is fueled by poor diets, high consumption of sugar, and lack of physical activity. As per the factsheet of the World Health Organization, approximately 90% of diabetic people are tending to suffer from overweight problems. Hence, the rising number of cases of diabetes is expected to increase the obesity that helps in increasing the demand for bariatric surgeries in Mexico. However, the high cost of these surgeries can hinder the market growth.
Key Market Trends
Closure Devices are Expected to Exhibit a Significant Growth Rate During the Forecast Period
Closure devices are used in bariatric procedures for reconnecting tissues and for the closing of incisions which are made through trocars. The growing cases of obesity are expected to increase the demand for these devices.
As per the data of Organisation for Economic Co-operation and Development, 2017, Mexico is the second highest obese country all around the world and by 2030 the number is expected to increase by 39%. Bariatric surgery is seen as one of the safest and stable methods to combat the morbidity of obesity, and closure devices play a crucial role in the surgical procedure. Therefore the improper closing of the incisions post-surgery can cause a hernia. Hence, the aforementioned factors are expected to drive market growth over the forecast period in this segment.
Some of the major players in the Mexico Bariatric Surgery Market are Medtronic Plc, Johnson & Johnson, Apollo Endosurgery, Inc., Aspire Bariatrics, Intuitive Surgical Inc., Olympus Corporation, ReShape Lifescience Inc., Boston Scientific Corporation and the Cooper Companies.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support